Status:
COMPLETED
Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study proposes to evaluate the effects of D-cycloserine (DCS) combined with Virtual Reality exposure therapy in a sample of patients who developed posttraumatic stress disorder (PTSD) following e...
Detailed Description
Participants with 9/11-related or military service in the Iraq War-related PTSD are assigned to one of two programs, following an initial assessment. Both programs include Virtual Reality Exposure The...
Eligibility Criteria
Inclusion
- English-speaking adults
- Between the ages of 18 and 70
- Exposed to the WTC Attacks (were in towers or in the immediate area) or veterans of the Iraq War
- Diagnosed with PTSD symptoms.
Exclusion
- Presence of current organic mental disorder
- Schizophrenia
- Bipolar disorder
- Depression with psychotic features
- Current substance dependence
- Delusional disorder
- Active suicidal ideation, intent, or plan
- Active homicidal ideation, intent, or plan
- Use of pacemaker
- Medically unstable
- Pregnant or lactating
- A history of severe renal disease
- History of seizures
- Currently taking anticoagulants, ethionamide (Trecator-SC) or isoniazid (INH)
- History of allergic reaction to cycloserine.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00632632
Start Date
January 1 2005
End Date
December 1 2012
Last Update
August 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College
New York, New York, United States, 10065